tiprankstipranks
Trending News
More News >
Intellia Therapeutics (DE:38I)
FRANKFURT:38I

Intellia Therapeutics (38I) Revenue

Compare
13 Followers

Intellia Therapeutics Revenue

Intellia Therapeutics had a revenue of 16.63M in the quarter ending Mar 31, 2025, with 29.15%. This bring the company's revenue in the last twelve months to 45.57M, Increased -21.27%. In the fiscal year ending Dec 31, 2024, Intellia Therapeutics had annual revenue of 57.88M with 59.55% growth.
Revenue (ttm)
45.57M
Revenue Growth
P/S Ratio
13.16
Revenue/Employee
$143,615
Employees
403
Market Cap
$761.69M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
57.88M21.60M+59.55%
Dec 31, 2023
36.27M-15.85M-30.40%
Dec 31, 2022
52.12M19.07M+57.69%
Dec 31, 2021
33.05M-24.94M-43.01%
Dec 31, 2020
57.99M14.89M+34.55%
Dec 31, 2019
43.10M12.67M+41.63%
Dec 31, 2018
30.43M4.32M+16.53%
Dec 31, 2017
26.12M9.64M+58.49%
Dec 31, 2016
16.48M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis